Figure 3From: Class III β-tubulin is a predictive marker for taxane-based chemotherapy in recurrent and metastatic gastric cancer PFS in patients with advanced gastric cancer according to the expression of class III β-tubulin (TUBB3) (high- vs. low-level expression; 3.63 vs. 6.67 months, P = 0.001) (solid line, low-level TUBB3 expression; dotted line, high-level TUBB3 expression). Back to article page